Flourish Research

Clinical trial optimization and operations efficiency

Flourish Research

Clinical trial optimization and operations efficiency

Overview

Flourish Research helps healthcare and pharmaceutical clients run clinical trials more efficiently. It offers tailored optimization services that improve trial operations, aiming to reduce time and costs to bring new treatments to market. The company leverages decades of experience to provide quality-driven solutions, focusing on expanding capabilities, developing healthy teams, and implementing processes that enhance speed and quality across trial activities. Flourish Research differentiates itself by its client-specific approaches and strong emphasis on quality, team development, and operational excellence to deliver reliable trial outcomes.

Work here?Claim your company

About Flourish Research

Simplify's Rating

Not yet rated

We're working on gathering enough insights on this company, check back soon!

Industries

Data & AnalyticsConsultingHealthcare

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Apex, null

Founded

2021

Get referred to Flourish Research

See people who can refer or advise you

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Tuition Reimbursement
Parental Leave
Employee Referral Bonus
Life Insurance
Disability Insurance
Paid Vacation
Paid Holidays
Paid Sick Leave

Company News

Yahoo Finance

Feb 26th, 2026

Flourish Research partners with Capitol Imaging Services to launch advanced PET imaging centre in Georgia

Flourish Research has partnered with Capitol Imaging Services ahead of launching Flourish Imaging, an advanced imaging centre in Gainesville, Georgia. The facility will feature a GE HealthCare Omni PET scanner and is expected to open in the coming months. Capitol Imaging Services will handle retail booking, scheduling and community outreach, whilst Flourish Imaging will expand clinical trial infrastructure, particularly for CNS and oncology studies. The scanner will enable high-resolution molecular imaging for tracer trials and complex research endpoints. Flourish Research operates over 30 wholly-owned clinical trial sites across North America, conducting Phase I–IV studies in oncology, neuroscience, cardiovascular and metabolic indications. The partnership aims to advance both clinical research capabilities and community diagnostic access in the region.

Greenville Business Magazine

Oct 8th, 2025

Greenville Business Magazine | Your Business Resource for Greenville Metro & Upstate South Carolina

Partnership Broadens Access to Advanced Cancer Clinical Trials and Strengthens Flourish's Presence in Southern California

BioBuzz

Mar 6th, 2025

Flourish Research expands with acquisition of California clinical trials company

In 2024, Genstar Capital, a San Francisco private equity firm with $49 billion under management, acquired a majority interest in Flourish from NMS Capital.

PR Newswire

Feb 18th, 2025

Flourish Research Acquires Diablo Clinical Research

Flourish Research, a multi-site clinical trial organization, announced its acquisition of Diablo Clinical Research, a facility known for phase I-IV trials and medical device studies. This acquisition expands Flourish's geographic footprint and therapeutic coverage. Diablo, established in 1995 and based in Walnut Creek, CA, enhances Flourish's access to Silicon Valley. Genstar Capital, which acquired Flourish in 2024, supports this growth. Fairmount Partners advised Diablo on the deal.

LexBlog

Sep 20th, 2024

Healthcare & Life Sciences Private Equity Deal Tracker: Genstar Invests in Flourish Research

Genstar Capital has announced a strategic majority investment in Flourish Research, according to a news release.

Recently Posted Jobs